INTRODUCTION
Extended-spectrum β-lactamases (ESBLs) are the enzymes, mostly encoded by plasmids in result of mutation due to which bacteria show resistance to various β-lactam antibiotics including cephalosporins and monbactams. 1 Beyond one hundred and fifty various ESBLs have been described and majority of them belong to class A enzymes (SHV, TEM and CTX-M).
2 ESBLs are most commonly found in bacteria (G -) especially the members of Enterobacteriaceae family. An increase in prevalence of ESBLs has been documented in recent years but it varies in different geographical areas of the world. septicemia and wound infections among children. 4 Apart from the other members of Enterobacteriaceae family, ESBLs are highly prevalent in K. pneumoniae. 5 Global data show that the rate of ESBL producing bacteria was highest among K. pneumoniae isolated from fourty four percent in America followed by twenty two percent Asia pacific, thirty three percent in Europe and seven percent in North America.
6
Many nosocomial outbreaks caused by ESBL K. pneumoniae have been reported among paediatric patients. ESBL K. pneumoniae are associated with high mortality rate among children. 7 Many tests have been recommended for the detection of ESBL production in vitro. The most commonly used methods include double disc synergy test, combined disc method and E-test. Several automated systems have also been developed for detection and some laboratories use molecular methods for detection of ESBL phenomenon.
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There are limited number of antibiotic options available to treat the infections caused by ESBL producing strains. 9 Present study was conducted with the objective, to evaluate the frequency of ESBL producing K. pneumoniae and comparison of detection methods among various clinical samples collected from a tertiary care children hospital. The early detection of ESBL producing K. pneumoniae strains can help to reduce high morbidity and mortality in paediatric patients.
METHODOLOGY
The study was conducted at the Microbiology Department of The Children's Hospital and Institute of Child Health Lahore, Pakistan, from May 2010 to February 2012. Eleven pathological samples including blood, cerebro-spinal fluid (CSF), urine, sputum, peritoneal dialysis catheters, tracheal secretions and pus were collected from paediatric patients were analysed during the study period. The patient's history regarding the use of various interventions like intravenous line, urinary catheters, endotracheal tube, lumber puncture, peritoneal dialysis catheters, exchange transfusion, nasogastric tube, surgery, central venous pressure line and tracheostomy was also noted. The Brain Heart Infusion Broth (BHI) was used to inoculate the blood samples and after a period of incubation they were sub-cultured on solid media. All of the clinical samples were cultured on different solid media of Blood, Chocolate and MacConkey agar plates (90mm) while the urine samples were cultured only on Cystine Lysine Electrolyte Deficient Medium (CLED). An overnight incubation of these culture plates was done at 37±1ºC in an incubator. The bacterial strains were identified using API 20E system (bioMerieux). Only the K. pneumoniae strains were included and processed further for ESBL detection. The culture media and antibiotic discs were purchased from Oxoid.
The K. pneumoniae strains were screened as ESBL screening-positive on the basis of resistance to ceftazidime. The screen positive K. pneumoniae strains were further processed for double disc synergy test (DDST) and Clinical Laboratory Standard Institute (CLSI) confirmatory test. In DDST, a disc of amoxicillin-clavulanic acid (AMC) was placed in the center of Mueller-Hinton agar plate (90mm) at 20mm distance to ceftazidime (CAZ 30μg) and cefotaxime (CTX 30μg). ESBL production was detected by the appearance of key hole effect due to the enhanced activity of ceftazidime and cefotaxime with clavulanic acid.
Both DDST positive and negative K. pneumoniae strains were analysed by CLSI confirmatory test. The CLSI confirmatory test was performed with of ceftazidime (CAZ 30μg) and cefotaxime (CTX 30μg) alone and using a combined disc of ceftazidimeclavulanic acid and cefotaxime-clavulanic acid (CAZ/CLA and CTX/CLA 30/10 μg). The CLSI confirmatory test was considered positive when the inhibition zone produced by the combined effect of ceftazidime or cefotaxime and clavulanic acid increased ≥5 mm than ceftazidime or cefotaxime without the clavulanic acid.
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RESULTS
A total number of 710 K. pneumoniae were isolated during the study period. Out of 710 positive culture 214 (30.1%) were ESBL screening-positive K. pneumoniae and 496 (69.9%) were screeningnegative positive K. pneumoniae.
Initial screening of K. pneumoniae isolates with ceftazidime showed positivity in all of the isolates. Comparison between DDST and CLSI confirmatory test showed that 145 (67.8%) isolates were identified by DDST and 213 (99.5%) by using CLSI confirmatory test (Table-I ). The CLSI confirmatory test had significantly (p<0.0001) higher sensitivity. Frequency distribution of ESBL K. pneumoniae was found to be highest in the blood samples 117 (54.7%) followed by urine 46 (21.5%), endotracheal tube 13 (6.1%), cerebro-spinal fluid 13 (6.1%) and peritoneal dialysis catheters 10 (4.7%). The rest of the samples showed the lesser occurrence of ESBL producing K. pneumoniae (Table-II) .
The frequency of various interventions among the 214 ESBL K. pneumoniae positive cases showed that most of the patients had intravenous line 209 (97.7%) followed by urinary catheters 46 (21.5%), endotracheal tube 18 (8.4%), lumber puncture 18 (8.4%) and peritoneal dialysis catheters 16 (7.5%). The less common interventions were exchange transfusion, nasogastric tube, surgery, central venous pressure line and tracheostomy (Table-III) .
DISCUSSION
ESBL producing K. pneumoniae is an important clinical pathogen responsible for life threatening infections especially among neonates and infants.
This study provides the recent data about the frequency distribution and comparison of phenotypic detection methods used to characterise ESBL producing K. pneumoniae from various clinical samples of children.
In our study frequency of ESBL producing K. pneumoniae is 30.1% which is lower than few other studies. A research work conducted in Pakistan Institute of Medical Sciences reported a high frequency of 70% ESBL producing K. pneumoniae.
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Another research study conducted in different hospitals of Iran reported 59.2% ESBL K. pneumoniae. 12 A study conducted in Lucknow, India reported 56% ESBL K. pneumoniae among neonates who had septicemia. 13 Frequency of ESBL producing K. pneumoniae is not very high in our study in comparison with other studies. The prevalence of ESBL K. pneumoniae varies from one institution to another depending upon the level of cleanliness and infection control measures.
Comparison of DDST and CLSI showed that most of the ESBL positive K. pneumoniae were detected by CLSI (99.5%) confirmatory test (p<0.0001) than DDST (67.8%). CLSI even detected ESBLs in those 69 isolates which were missed by DDST. Dalela worked on ESBLs at Jhalawar Medical College in India, used DDST and CLSI for detection of ESBLs in gram-negative bacteria. Out of his 135 screening positive ESBL isolates, DDST detected ESBLs in 122 (90%) isolates while CLSI detected ESBLs in all isolates (100%).
14 Similarly another study conducted at Microbiology department of Sher-iKashmir Institute of Medical Sciences, KashmirIndia also compared DDST and CLSI methods in detection of ESBL production in K. pneumoniae. Out of 92 screen positive isolates, DDST detected ESBL production in 32 (34.8%) isolates while CLSI detected ESBLs in 72 (78.3%) isolates.
3 A study conducted by Dhara et al reported that DDST detected only 75% isolates with ESBLs while CLSI detected ESBLs in 85.4% of K. pneumoniae isolated from neonatal intensive care unit patients. 15 In our experience CLSI missed only 1 (0.5%) isolate. One group of researchers reported 15.2% false negativity with CLSI methods among the screening positive isolates. 16 Our findings supports the results of most the previous findings suggesting that CLSI confirmatory test is more reliable in detection of the ESBL K. pneumoniae than the other phenotypic methods.
Hasan Ejaz et al. Frequency distribution of ESBL producing K. pneumoniae varied among different pathological samples, a high percentage of 54.7% was isolated from blood followed by urine (21.5%), cerebrospinal fluid (6.1%) and pus (1.4%). Frequency of ESBL producing K. pneumoniae in different clinical samples was also reported in a study conducted at 1000 bed teaching hospital, Spain. A very high percentage of K. pneumoniae was found in blood (40%) and catheters (36%) followed by respiratory fluid (26%), urine (23%) and pus (18%). 17 Similarly a research work conducted at Agha Khan University, Karachi reported high percentage of ESBL positive K. pneumoniae in blood (60%), urine (24%) and wound (6%). 18 Ahmad et al also reported more of the ESBL producing K. pneumoniae strains from blood (44.9%) while less frequency was observed in urine (16.2%), tracheal secretions (10.9%), wound (5.9%) and endo-tracheal tip (5.9%). 3 The results of these studies are in agreement with our findings indicating the detection of most of the ESBLs in patients with bacteremia.
In our study we found that most of the patients with ESBL K. pneumoniae infections had some interventions like intravenous lines (97.7%) and urinary catheters (21.5%). A study reported the association of invasive procedures like urinary catheters 6 (26.1%), surgeries (26.1%) and mechanical ventilation 3 (13.0%) among the ESBL positive cases of K. pneumoniae. 19 In another study the most common interventions found in 79 cases of ESBL K. pneumoniae infections were central venous catheters 72 (91.1%), urinary catheters 70 (88.6%), surgeries 66 (83.5%), nasogastric tube 56 (70.9%) and tracheostomy 37 (46.8%). 20 The ESBL K. pneumoniae infections can vary in patients depending upon the various interventions and how they were used. The intravenous lines and catheters can be a good source infection if not used aseptically.
CONCLUSION
ESBL producing K. pneumoniae is a serious concern for the hospitals. It is associated with high morbidity among paediatric patients which results in high cost of treatment. An appropriate antimicrobial therapy can only be started timely with the early detection of ESBLs. The CLSI confirmatory test can be used reliably especially when the facilities for molecular charaterization are not available. The detection of ESBL producing strains will also help to establish and implement a strict infection control policy to stop the spread of ESBL K. pneumoniae.
